Skip to content

Machine Learning for Reclassification of Obesity

Data-driven Clustering for Metabolic Classification of Obesity Using Machine Learning

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04282837
Enrollment
2495
Registered
2020-02-25
Start date
2020-03-01
Completion date
2020-06-20
Last updated
2020-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Obesity, Machine learning, Metabolic classification, Clustering, Bariatric surgery

Brief summary

The goal of this study is to employ or develop computational modeling techniques for the precise reclassification of obesity into subgroups. Clinical features, risks of noncommunicable diseases, as well as weight loss effects of bariatric surgery will also be studied and compared within the subgroups.

Interventions

DIAGNOSTIC_TESTAI classification of patients with obesity

Computational modeling techniques will be used for the precise reclassification of obesity into four subgroups, several variables according to the clinical experience and the modeling results will be selected for the cluster analysis.

Sponsors

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
CollaboratorOTHER
The Third People's Hospital of Chengdu
CollaboratorOTHER
Shanghai East Hospital
CollaboratorOTHER
University of Pittsburgh
CollaboratorOTHER
Shanghai 10th People's Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
10 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

1. Patients with overweight/obesity 2. Patients with normal weight as controls

Exclusion criteria

1. had ever been performed with a bariatric surgery before the study's first visit is scheduled; 2. had taken exogenous insulin, medication that affects glucose metabolism, or uric acid drugs currently; 3. being diagnosed with type 1 diabetes, secondary diabetes, hereditary disease, or severe disease (e.g. malignant tumor, heart failure, liver failure, etc.); 4. in gestation of lactation; 5. did not have the complete data for model; 6. for normal-weight controls, patients with diabetes or hyperuricemia were excluded.

Design outcomes

Primary

MeasureTime frame
Metabolic classification of patients with obesity using machine learningbaseline

Secondary

MeasureTime frame
Metabolic features in patients of different subgroupsbaseline
Risks for noncommunicable disease in patients of different subgroupsbaseline
Effect of bariatric surgery in patients of different subgroups1 year after bariatric surgery

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026